CLICK HERE TO STREAM CoHO LIVE
*You must be registered for CoHO 2025 to view the livestream. If you are not registered, please register using the Registration button on this page before streaming.
Welcome
We are very pleased to announce the Conference on Hematology and Oncology (CoHO) will be taking place on November 7 & 8, 2025.
In the last year, many advancements have been made in oncology and hematology and we are eager to pursue our continued education as it is so crucial to the advancement of treatment for our patients.
Our objective is to provide high quality education and an opportunity to network with our colleagues. CoHO will focus on advancements in Hematology including; Lymphoma, CLL, and Myeloma, and in Oncology including; Breast, Lung, and GI.
Oncologists and hematologists as well as physicians in other disciplines, GPOs, residents, nurse practitioners and pharmacists, will come together in an environment where challenging cases can be discussed, and best practices shared. There will be keynote presentations on new and relevant data followed by panel discussions. At this time facilitators can present a series of interactive case discussions with audience participation. By keeping the program interactive, we will be successful in engaging the audience and enhance learning.
We hope you will be joining us for CoHO!
Sincerely,
Dr. Wendy Lam,
CoHO Chair, Burnaby Hospital Regional Cancer Centre
On behalf of the CoHO Planning Committee
– Dr. Barbara Melosky, BC Cancer
– Dr. Laurie Sehn, BC Cancer
– Dr. Simon Yu, Burnaby Hospital Regional Cancer Centre
Accreditation:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.
This activity was approved by the Canadian Association of Medical Oncologists for a maximum of 11.5 hours.
Learning Objectives:
- Describe new practice-changing developments in malignant hematology and medical oncology in 2025
- Select the appropriate clinical conditions in oncology and hematology using newly developed 2025 treatments
- Identify risks and benefits of new treatments
- Describe the most important management issues in hematology/oncology and select the best treatments based on current evidence
- Apply best evidence for patient management using case based approach